At VitaWave, our mission is to enhance patient outcomes by revolutionizing blood pressure monitoring, thereby improving the management of hypertensive patients.
We have developed an innovative In-ear Blood Pressure (eBP) monitoring device designed to be cuffless, portable, and capable of intermittent and continuous remote monitoring. Studies have demonstrated that our device accurately measures diastolic and systolic blood pressure, consistently falling within the FDA's established tolerance limits.
We currently have one patent pending for our groundbreaking technology.
Our eBP device is tailored for patients and healthcare providers who require frequent blood pressure monitoring. It offers a unique solution by delivering cuffless, portable, and accurate blood pressure measurements, enabling effective management of hypertension in a convenient and user-friendly manner.
Join us on our journey to transform healthcare through innovative technology!
Company Details
- Employees
- 3
- Founded
- -
- Address
- 2589 Briarwood Dr, Boulder,colorado 80305,united States
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://vitawavetech.com
- HQ
- Boulder, Colorado
Vitawave Tech Inc. Questions
Vitawave Tech Inc.'s website is https://vitawavetech.com
Vitawave Tech Inc.'s LinkedIn profile is https://www.linkedin.com/company/vitawave-tech-inc
Vitawave Tech Inc. has
3 employees.
View email and phone details for 3
employees at Vitawave Tech Inc..
Vitawave Tech Inc.'s industry is
Medical Equipment Manufacturing
Vitawave Tech Inc.'s top competitors are
Decorum Medical Innovations,
Inotiv,
Eonminds,
Sayenza Biosciences,
Hyprskn,
Obsolete Engineering,
Aidc,
Patchwork,
Intelligems,
Pitch Sink.
Vitawave Tech Inc.'s categories are Medical Equipment Manufacturing
Vitawave Tech Inc.'s founding year is 2023
